Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.315 USD | +7.03% | +11.92% | +24.55% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.60% | 723M | |
+9.59% | 114B | |
+11.54% | 104B | |
-13.98% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.36% | 17.89B | |
+7.17% | 14.28B | |
+35.90% | 12.55B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Earnings Flash (WVE) WAVE LIFE SCIENCES USA Reports Q2 Revenue $22.1M, vs. Street Est of $7.9M